Company Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES
Equities
0IVI
DK0060048148
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- DKK | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 16-02-29 |
Chief Tech/Sci/R&D Officer | - | 17-09-12 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 16-02-29 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 16-03-31 |
Rita L. Mannella
HRO | Human Resources Officer | - | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,739,741,590 | 173,932,405 ( 9.998 %) | 0 | 9.998 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+19.29% | 80.5B | |
+15.08% | 9.15B | |
-18.33% | 4.9B | |
+43.39% | 4.49B | |
+13.95% | 4.44B | |
+10.89% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- VELO Stock
- 0IVI Stock
- Company Veloxis Pharmaceuticals A/S